Ballarat Health Service
Ventilator-associated pneumonia more prevalent in antibiotic prevention studies
Published in Disease Risk Factor Week, July 3rd, 2005
According to a recently published study from Australia, "Ventilator-associated pneumonia (VAP) rates were compared with patterns of isolates across studies of antibiotic and nonantibiotic methods for preventing VAP."
"With the use of 42 cohort study groups as the reference standard, the prevalence of VAP was modeled in two linear regressions: one with the control groups and the other with the intervention groups of 96 VAP prevention studies.
"The proportion of patients admitted with trauma and the VAP diagnostic criteria were used as ecologic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Disease Risk Factor Week
More Articles from Disease Risk Factor Week
- Disease Prevention
Health experts, African leaders discuss development of anti-HIV gel prophylaxis - Foundation for Community Development, Mozambique
African leaders meet international health officials to discuss microbicides - Home Safety Council
National survey finds parents need to take actions to create a safer home - A-Fem Medical Corporation
Medical technology company completes $1.18M private placement - A.C.T. Holdings, Inc.
Cloning, cellular reprogramming agreements signed - ACT NOW
Telemedicine, 'stroke box' initiatives get help to acute stroke victims quickly - More from this issue of Disease Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
